Division of Paediatric Gastroenterology, Hepatology and Nutrition, Department of Paediatrics, UH Rainbow Babies and Children's hospital/Case Western Reserve University School of Medicine, Cleveland, Ohio, USA.
Division of Paediatric Cardiology, Department of Paediatrics, Rush University Medical Centre, Chicago, Illinois, USA.
Pediatr Obes. 2021 Aug;16(8):e12777. doi: 10.1111/ijpo.12777. Epub 2021 Mar 14.
Severe sepsis is one of the leading causes of mortality among children. Studies in adults have suggested a protective effect of obesity on mortality among patients hospitalized with sepsis. Paediatric studies evaluating similar relationship is lacking.
We analysed non-overlapping years of the Kids Inpatient Database (KID) and National Inpatient Sample (NIS) database between 2003 and 2014 of all paediatric patients with severe sepsis (PSS) up to 20 years of age. PSS was defined using specific International Classification of Diseases (ICD) codes and modified Angus criteria. Using ICD-9 diagnosis codes, patients were divided into three mutually exclusive groups (obesity, morbid obesity and control groups), and these groups were compared for outcomes measures including in-hospital mortality and healthcare resource utilization using the length of stay and inflation-adjusted hospitalization charges.
We analysed 109 026 hospitalizations due to PSS. The prevalence rate of obesity was 1.5% (n = 1643), and morbid obesity was 1.05% (n = 1147). Multivariate regression models showed obesity was associated with 63% (OR 0.37, CI: 0.29-0.47, p < 0.001) and 54% reduction in mortality among PSS patients and patients with septic shock respectively. Contrastingly, morbid obesity was not associated with mortality among PSS patients and but was associated with 1.37 times (CI: 1.06-1.78, p = 0.01) increased risk of mortality among paediatric patients with septic shock.
Paediatric obesity is associated with reduced mortality among patients with PSS, with the exception of morbid obesity. Further prospective studies are needed to better understand the relationship between obesity and outcomes in PSS.
严重脓毒症是导致儿童死亡的主要原因之一。成人研究表明,肥胖对脓毒症住院患者的死亡率有保护作用。儿科研究评估类似的关系则有所欠缺。
我们分析了 2003 年至 2014 年期间 Kids Inpatient Database(KID)和 National Inpatient Sample(NIS)数据库中非重叠年份的所有年龄在 20 岁以下患有严重脓毒症(PSS)的儿科患者数据。使用特定的国际疾病分类(ICD)代码和改良 Angus 标准来定义 PSS。使用 ICD-9 诊断代码,患者被分为三个互斥的组(肥胖组、病态肥胖组和对照组),并用住院时间和通胀调整后的住院费用来比较这些组的住院死亡率和医疗资源利用情况等结果测量指标。
我们分析了 109026 例因 PSS 住院的患者。肥胖的患病率为 1.5%(n=1643),病态肥胖的患病率为 1.05%(n=1147)。多变量回归模型显示,肥胖与 PSS 患者和感染性休克患者的死亡率分别降低了 63%(OR 0.37,95%CI:0.29-0.47,p<0.001)和 54%。相反,病态肥胖与 PSS 患者的死亡率无关,但与感染性休克患儿的死亡率增加 1.37 倍相关(95%CI:1.06-1.78,p=0.01)。
儿科肥胖与 PSS 患者的死亡率降低有关,除了病态肥胖。需要进一步的前瞻性研究来更好地了解肥胖与 PSS 患者结局之间的关系。